46
Participants
Start Date
March 13, 2017
Primary Completion Date
June 3, 2019
Study Completion Date
July 31, 2019
PrEP (Truvada)
oral, daily Truvada for HIV-negative participants
Antiretrovirals
oral daily antiretrovirals and frequent viral load monitoring for HIV-positive participant
Semen washing
collection of semen from an HIV-positive man, processing semen to remove HIV, followed by intrauterine insemination
Artificial vaginal insemination
collection of semen from an HIV-negative man, followed by intravaginal insemination
UZCHS-UCSF CTRC Zengeza Clinical Research Site, Harare
Collaborators (1)
UZ-UCSF Collaborative Research Programme
OTHER
National Institute of Mental Health (NIMH)
NIH
Gilead Sciences
INDUSTRY
University of California, San Francisco
OTHER